| Title： | Chinese Public Guideline for the Management of Stable Ischemic Heart Disease |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Prevention |
| Countries and regions： | China |
| Guidelines users： | Healthy people and people at high risk for cognitive decline and dementia in all regions of China |
| Evidence classification method： | The GRADE method was used to evaluate the quality of evidence related to cognitive decline and dementia. According to the GRADE method, the quality of evidence is divided into high quality, moderate quality, low quality, and very low quality. In the evidence grading process, there are five downgrading factors: limitations, imprecision, inconsistency, indirectness, and publication bias, and three upgrading factors: large effect size, dose-response relationship and possible confounders (negative bias). |
| Development unit： | Chinese Health Rlsk MAnagement Collaboration (CHRIMAC) |
| Registration time: | 2023-12-11 |
| Registration number： | PREPARE-2023CN178 |
| Purpose of the guideline: | Stable ischemic heart disease has emerged as a significant health burden in China, with a consistent rise in recent years attributed to lifestyle changes and social developments. The guidelines aimed to mitigate the risk of ischemic heart disease and enhance cardiovascular health in the public by providing practical and personalized health recommendations, such as advocating for healthy lifestyles, making wise dietary choices, and encouraging moderate exercise, through the latest epidemiological evidence. |
Latest registration
